386 related articles for article (PubMed ID: 19072688)
1. Discovery of potent thermolysin inhibitors using structure based virtual screening and binding assays.
Khan MT; Fuskevåg OM; Sylte I
J Med Chem; 2009 Jan; 52(1):48-61. PubMed ID: 19072688
[TBL] [Abstract][Full Text] [Related]
2. Fragment-based lead discovery: screening and optimizing fragments for thermolysin inhibition.
Englert L; Silber K; Steuber H; Brass S; Over B; Gerber HD; Heine A; Diederich WE; Klebe G
ChemMedChem; 2010 Jun; 5(6):930-40. PubMed ID: 20394106
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel quinazolin-4(3H)-ones as inhibitors of thermolysin, the prototype of the M4 family of proteinases.
Khan MT; Khan R; Wuxiuer Y; Arfan M; Ahmed M; Sylte I
Bioorg Med Chem; 2010 Jun; 18(12):4317-27. PubMed ID: 20494587
[TBL] [Abstract][Full Text] [Related]
4. In silico fragment-based discovery of DPP-IV S1 pocket binders.
Rummey C; Nordhoff S; Thiemann M; Metz G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1405-9. PubMed ID: 16321524
[TBL] [Abstract][Full Text] [Related]
5. Specific interactions and binding energies between thermolysin and potent inhibitors: molecular simulations based on ab initio molecular orbital method.
Hirakawa T; Fujita S; Ohyama T; Dedachi K; Khan MT; Sylte I; Kurita N
J Mol Graph Model; 2012 Mar; 33():1-11. PubMed ID: 22112671
[TBL] [Abstract][Full Text] [Related]
6. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
[TBL] [Abstract][Full Text] [Related]
7. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
Mizutani MY; Itai A
J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
[TBL] [Abstract][Full Text] [Related]
8. Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
Miguet L; Zervosen A; Gerards T; Pasha FA; Luxen A; Distèche-Nguyen M; Thomas A
J Med Chem; 2009 Oct; 52(19):5926-36. PubMed ID: 19746934
[TBL] [Abstract][Full Text] [Related]
9. Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational docking.
Jenkins JL; Shapiro R
Biochemistry; 2003 Jun; 42(22):6674-87. PubMed ID: 12779322
[TBL] [Abstract][Full Text] [Related]
10. Docking methods for structure-based library design.
Cavasotto CN; Phatak SS
Methods Mol Biol; 2011; 685():155-74. PubMed ID: 20981523
[TBL] [Abstract][Full Text] [Related]
11. Binding of phosphorus-containing inhibitors to thermolysin studied by the Poisson-Boltzmann method.
Shen J; Wendoloski J
Protein Sci; 1995 Mar; 4(3):373-81. PubMed ID: 7795520
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the action of thermolysin.
Tronrud DE; Roderick SL; Matthews BW
Matrix Suppl; 1992; 1():107-11. PubMed ID: 1480010
[TBL] [Abstract][Full Text] [Related]
13. A theoretical investigation of tight-binding thermolysin inhibitors.
Shen J
J Med Chem; 1997 Aug; 40(18):2953-8. PubMed ID: 9288178
[TBL] [Abstract][Full Text] [Related]
14. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
[TBL] [Abstract][Full Text] [Related]
15. Enhanced virtual screening by combined use of two docking methods: getting the most on a limited budget.
Maiorov V; Sheridan RP
J Chem Inf Model; 2005; 45(4):1017-23. PubMed ID: 16045296
[TBL] [Abstract][Full Text] [Related]
16. Novel non-peptide beta-secretase inhibitors derived from structure-based virtual screening and bioassay.
Xu W; Chen G; Liew OW; Zuo Z; Jiang H; Zhu W
Bioorg Med Chem Lett; 2009 Jun; 19(12):3188-92. PubMed ID: 19447035
[TBL] [Abstract][Full Text] [Related]
17. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy.
Cross JB; Thompson DC; Rai BK; Baber JC; Fan KY; Hu Y; Humblet C
J Chem Inf Model; 2009 Jun; 49(6):1455-74. PubMed ID: 19476350
[TBL] [Abstract][Full Text] [Related]
18. In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase.
Brooks WH; McCloskey DE; Daniel KG; Ealick SE; Secrist JA; Waud WR; Pegg AE; Guida WC
J Chem Inf Model; 2007; 47(5):1897-905. PubMed ID: 17676832
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening strategies in drug discovery.
McInnes C
Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
